EU Approves Remdesivir As COVID-19 Drug

The European Commission (EU) has approved the use of Remdesivir, an antiviral drug for severe Coronavirus cases.

EU Health Commissioner Stella Kyriakides made this known in a statement on Friday.

According to Stella, the drug has the tendency of speeding up recovery rate in COVID-19 patients.

“Today’s authorisation of a first medicine to treat COVID-19 is an important step forward in the fight against this virus.

“We are granting this authorisation less than a month after the application was submitted, showing clearly the EU’s determination to respond quickly whenever new treatments become available

Remdesivir is an anti viral drug created initially for treating Ebola and has at the same time proven to be the only anti-coronavirus medication approved by the EU.

---

Advertise or Publish a Story on EkoHot Blog:

Kindly contact us at [email protected]. Breaking stories should be sent to the above email and substantiated with pictorial evidence.

Citizen journalists will receive a token as data incentive.

Call or Whatsapp: 0803 561 7233, 0703 414 5611